Prenatal Exposure to Select Phthalates and Phenols and Associations with Fetal and Placental Weight among Male Births in the EDEN Cohort (France).


Journal

Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 10 1 2019
pubmed: 10 1 2019
medline: 11 4 2019
Statut: ppublish

Résumé

The placenta performs crucial physiological functions to ensure normal fetal development. Few epidemiological studies investigated placental weight sensitivity to phthalates and phenols. Our goal was to explore whether maternal exposure to select phthalates and phenols is associated with changes in placental weight at birth and in placental–to–birth weight ratio (PFR). Placental weight and birth weight were available for 473 mother–son pairs in the EDEN (Etude des Déterminants pré et postnatals du développement et de la santé de l'Enfant) cohort for whom 9 phenols (4 parabens, 2 dichlorophenols, triclosan, benzophenone-3, bisphenol A) and 11 phthalate metabolites were measured in spot urine samples collected between weeks 23 and 29 of gestation. We used adjusted Elastic Net penalized regression models (ENET) to select biomarkers associated with placental weight, birth weight and PFR. Unpenalized effect estimates were then obtained by fitting linear regression models simultaneously adjusted for the ENET-selected biomarkers and The multipollutant ENET model for placental weight retained four biomarkers: triclosan and monocarboxy-isononyl phthalate (MCNP), which were negatively associated with placental weight, and benzophenone-3 and the sum of parabens, which were positively associated with this outcome. The ENET model for PFR retained two phthalate metabolites [MCNP and monocarboxy-isooctyl phthalate (MCOP)], which were negatively associated with this outcome. The positive association between the sum of parabens and placental weight was consistent with results of a previous study among 49 male births. Our results provide preliminary evidence of possible associations between other compounds such as triclosan, benzophenone-3, MCNP, and MCOP and both placental weight and PFR. These associations were not reported in previous studies and should be seen as hypothesis generating. Studies relying on repeated assessments of exposure in prospective mother–child cohorts are needed to substantiate the plausibility of the hypotheses generated by our results. https://doi.org/10.1289/EHP3523.

Sections du résumé

BACKGROUND
The placenta performs crucial physiological functions to ensure normal fetal development. Few epidemiological studies investigated placental weight sensitivity to phthalates and phenols.
OBJECTIVE
Our goal was to explore whether maternal exposure to select phthalates and phenols is associated with changes in placental weight at birth and in placental–to–birth weight ratio (PFR).
METHODS
Placental weight and birth weight were available for 473 mother–son pairs in the EDEN (Etude des Déterminants pré et postnatals du développement et de la santé de l'Enfant) cohort for whom 9 phenols (4 parabens, 2 dichlorophenols, triclosan, benzophenone-3, bisphenol A) and 11 phthalate metabolites were measured in spot urine samples collected between weeks 23 and 29 of gestation. We used adjusted Elastic Net penalized regression models (ENET) to select biomarkers associated with placental weight, birth weight and PFR. Unpenalized effect estimates were then obtained by fitting linear regression models simultaneously adjusted for the ENET-selected biomarkers and
RESULTS
The multipollutant ENET model for placental weight retained four biomarkers: triclosan and monocarboxy-isononyl phthalate (MCNP), which were negatively associated with placental weight, and benzophenone-3 and the sum of parabens, which were positively associated with this outcome. The ENET model for PFR retained two phthalate metabolites [MCNP and monocarboxy-isooctyl phthalate (MCOP)], which were negatively associated with this outcome.
DISCUSSION
The positive association between the sum of parabens and placental weight was consistent with results of a previous study among 49 male births. Our results provide preliminary evidence of possible associations between other compounds such as triclosan, benzophenone-3, MCNP, and MCOP and both placental weight and PFR. These associations were not reported in previous studies and should be seen as hypothesis generating. Studies relying on repeated assessments of exposure in prospective mother–child cohorts are needed to substantiate the plausibility of the hypotheses generated by our results. https://doi.org/10.1289/EHP3523.

Identifiants

pubmed: 30624098
doi: 10.1289/EHP3523
pmc: PMC6381819
doi:

Substances chimiques

Biomarkers 0
Phenols 0
Phthalic Acids 0
phthalic acid 6O7F7IX66E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17002

Références

J Perinat Med. 1975;3(4):237-41
pubmed: 1225957
Anal Bioanal Chem. 2005 Oct;383(4):638-44
pubmed: 16132150
Occup Environ Med. 2005 Nov;62(11):806-18
pubmed: 16234408
Endocr Rev. 2006 Apr;27(2):141-69
pubmed: 16434511
Clin Sci (Lond). 2007 Jul;113(1):1-13
pubmed: 17536998
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 1;860(1):106-12
pubmed: 17997365
Environ Health Perspect. 2008 Apr;116(4):467-73
pubmed: 18414628
Acta Obstet Gynecol Scand. 2008;87(6):608-11
pubmed: 18568459
Environ Health Perspect. 2008 Aug;116(8):1092-7
pubmed: 18709157
Int J Toxicol. 2008;27 Suppl 4:1-82
pubmed: 19101832
Horm Res. 2009;72(5):257-65
pubmed: 19844111
Environ Health Perspect. 2012 Mar;120(3):464-70
pubmed: 21900077
Sci Total Environ. 2012 Jan 1;414:98-102
pubmed: 22142650
Epidemiology. 2012 Mar;23(2):353-6
pubmed: 22317818
Environ Health. 2012 Apr 26;11:29
pubmed: 22537080
Reprod Toxicol. 2012 Nov;34(3):385-92
pubmed: 22677473
Int J Hyg Environ Health. 2013 Jun;216(3):230-42
pubmed: 22795704
Environ Int. 2012 Nov 1;48:47-55
pubmed: 22836169
Environ Health Perspect. 2012 Dec;120(12):1753-9
pubmed: 22922820
Acta Obstet Gynecol Scand. 2013 May;92(5):583-90
pubmed: 23398315
Environ Pollut. 2013 Jul;178:115-20
pubmed: 23562958
Environ Health Perspect. 2013 Oct;121(10):1225-31
pubmed: 23942273
Environ Res. 2014 Aug;133:396-406
pubmed: 24972507
Epidemiology. 2014 Sep;25(5):625-35
pubmed: 25061923
Occup Environ Med. 2015 Jun;72(6):385-93
pubmed: 25209848
Acta Obstet Gynecol Scand. 2014 Dec;93(12):1302-8
pubmed: 25244579
Int J Environ Res Public Health. 2015 May 22;12(5):5657-84
pubmed: 26006133
Environ Health Perspect. 2016 Mar;124(3):365-72
pubmed: 26115335
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636
Front Physiol. 2016 Feb 05;7:28
pubmed: 26903878
Environ Health Perspect. 2016 Aug;124(8):1261-8
pubmed: 26908126
Epidemiology. 2016 May;27(3):378-88
pubmed: 27035688
J Hazard Mater. 2017 Feb 5;323(Pt A):177-183
pubmed: 27156397
Environ Health Perspect. 2016 Dec;124(12):1848-1856
pubmed: 27219331
Am J Epidemiol. 2016 Jun 15;183(12):1122-8
pubmed: 27257113
Environ Res. 2016 Nov;151:601-609
pubmed: 27596487
Chemosphere. 2017 Apr;172:29-36
pubmed: 28061343
Sci Rep. 2017 Mar 21;7:44803
pubmed: 28322267
Environ Res. 2017 Jul;156:505-511
pubmed: 28427038
Environ Res. 2018 Jan;160:239-246
pubmed: 29028488
Environ Int. 2018 Mar;112:243-250
pubmed: 29294443
Environ Health Perspect. 2018 Mar 16;126(3):037005
pubmed: 29553460
Am J Epidemiol. 2018 Jul 1;187(7):1354-1361
pubmed: 29584806
Environ Res. 2019 Feb;169:41-51
pubmed: 30412856
Environ Int. 2019 Jan;122:418
pubmed: 30594295
Am J Epidemiol. 1979 Aug;110(2):178-87
pubmed: 463872

Auteurs

Claire Philippat (C)

Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences (IAB), Inserm U1209, Centre national de la recherche scientifique (CNRS) Unité de recherche (UMR) 5309, Université Grenoble Alpes, Grenoble, France.

Barbara Heude (B)

Early Origin of the Child's Health and Development (ORCHAD) Team, Inserm 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre (CRESS), Villejuif, France.
Université Paris Descartes, Villejuif, France.

Jérémie Botton (J)

Faculty of Pharmacy, Université Paris-Sud/Université Paris-Saclay, Châtenay-Malabry, France.

Nadia Alfaidy (N)

Commissariat à l'Energie Atomique et aux Energies Alternatives, CNRS, Inserm U1036, Biosciences and Biotechnology Institute of Grenoble, Université Grenoble Alpes, Grenoble, France.

Antonia M Calafat (AM)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Rémy Slama (R)

Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences (IAB), Inserm U1209, Centre national de la recherche scientifique (CNRS) Unité de recherche (UMR) 5309, Université Grenoble Alpes, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH